Hologic (HOLX) Competitors

DexCom (NASDAQ:DXCM) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

Do institutionals and insiders hold more shares of DXCM or HOLX?

97.8% of DexCom shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 1.9% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer DXCM or HOLX?

DexCom presently has a consensus target price of $99.90, suggesting a potential upside of 23.91%. Hologic has a consensus target price of $78.00, suggesting a potential upside of 16.12%. Given DexCom's stronger consensus rating and higher probable upside, equities research analysts plainly believe DexCom is more favorable than Hologic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.96
Hologic	0 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.59

Does the media favor DXCM or HOLX?

In the previous week, DexCom had 19 more articles in the media than Hologic. MarketBeat recorded 34 mentions for DexCom and 15 mentions for Hologic. Hologic's average media sentiment score of 1.38 beat DexCom's score of 1.27 indicating that Hologic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	26 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	11 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is DXCM or HOLX more profitable?

Hologic has a net margin of 13.79% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Hologic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	13.29%	30.41%	10.08%
Hologic	13.79%	19.69%	10.82%

Which has higher earnings and valuation, DXCM or HOLX?

Hologic has lower revenue, but higher earnings than DexCom. Hologic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.03B	7.84	$576.20M	$1.44	55.99
Hologic	$4.03B	3.71	$789.50M	$2.41	27.87

Which has more volatility and risk, DXCM or HOLX?

DexCom has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500.

Summary

DexCom beats Hologic on 11 of the 17 factors compared between the two stocks.